Key facts
- Restora Medical’s last known valuation is $23.0M (Mar 2025).
- It has raised $9.5M across 3 recorded rounds; the latest was Early Stage VC ($11.5M) in May 2026.
- Notable investors include CJNV BioVentures, HM Venture Partners.
- Restora Medical has filed 3 Form Ds with the SEC since 2024, most recently May 2026 ($11.5M sold to 5 investors).
- Status: Privately Held (backing).
Investors
2- ·Post-money valuations for all 3 rounds
- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Restora Medical
Funding rounds
3 roundsAbout Restora Medical
Developer of a restorative sleep apnea therapy designed to treat obstructive sleep apnea through targeted nerve stimulation. The company offers an investigational medical device that stimulates airway muscles to maintain breathing during sleep, enabling patients with sleep apnea to achieve safer and more restful sleep.
- Sector
- Healthcare
- HQ
- Irvine, CA, United States
- Founded
- 2023
- Website
- restoramedical.com/
- Ownership
- Privately Held (backing)
Restora Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Restora Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Restora Medical in its N-PORT filings yet. We sweep new filings monthly.